PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1) - ANVISA Registration 10322250050

Access comprehensive regulatory information for PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10322250050 and manufactured by QIAGEN. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including QIAGEN, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
1 Competitors
10322250050
Registration Details
ANVISA Registration Number: 10322250050
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

AmniSure – Teste para Detecção de Ruptura de Membrana Fetal
Risk Class II

Registration Details

10322250050

25351377072201366

01334250000120

Company Information

QIAGEN
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Sep 02, 2013

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1)"